| Literature DB >> 23554727 |
Ashish Kumar Sharma1, Arshee Munajjam, Bhawna Vaishnav, Richa Sharma, Ashok Sharma, Kunal Kishore, Akash Sharma, Divya Sharma, Rita Kumari, Ashish Tiwari, Santosh Kumar Singh, Samir Gaur, Vijay Singh Jatav, Barthu Parthi Srinivasan, Shyam Sunder Agarwal.
Abstract
The present study investigated the effect of garlic (Allium sativum Linn.) aqueous extracts on ischemic preconditioning and ischemia-reperfusion induced cardiac injury, as well as adenosine involvement in ischemic preconditioning and garlic extract induced cardioprotection. A model of ischemia-reperfusion injury was established using Langendorff apparatus. Aqueous extract of garlic dose was standardized (0.5%, 0.4%, 0.3%, 0.2%, 0.1%, 0.07%, 0.05%, 0.03%, 0.01%), and the 0.05% dose was found to be the most effective. Higher doses (more than 0.05%) were highly toxic, causing arrhythmia and cardiodepression, whereas the lower doses were ineffective. Garlic exaggerated the cardioprotective effect of ischemic preconditioning. The cardioprotective effect of ischemic preconditioning and garlic cardioprotection was significantly attenuated by theophylline (1,000 µmol/L) and 8-SPT (10 mg/kg, i.p.) and expressed by increased myocardial infarct size, increased LDH level, and reduced nitrite and adenosine levels. These findings suggest that adenosine is involved in the pharmacological and molecular mechanism of garlic induced cardioprotection and mediated by the modulation of nitric oxide.Entities:
Keywords: Allium sativum Linn.; adenosine; cardioprotection; ischemic preconditioning; nitrite
Year: 2012 PMID: 23554727 PMCID: PMC3596077 DOI: 10.1016/S1674-8301(12)60004-9
Source DB: PubMed Journal: J Biomed Res ISSN: 1674-8301
Fig. 1Infarct size measurement.
A: Heart was mounted on Langendorff apparatus and transparent to 20 min ischemia and 40 min reperfusion. B: Ventricular sclices after triphenyltetrazoliumchloride (TTC) staining, placed between glass plates and transparent plastic grid placed on it. C: Representive ventricular sclices after TTC staining, placed between two glass plates and transparent plastic grid placed on it for calculation of percentage infarct size by volume method. D: Larger view of representive ventricular sclices after TTC staining, placed between two glass plates and transparent plastic grid placed on it for calculation of percentage infarct size by volume method. Yellow part represents infarcted part and pink part shows viable part after 20 min ischemia and 40 min reperfusion.
Fig. 2Diagrammatic representation of the experimental protocol.
I, R, S denotes ischemia, reperfusion and stabilization, respectively.
Coronary flow rate in isolated rat heart subjected to global ischemia (20 min) and reperfusion (40 min).
| Groups | Basal | 5 min | 10 min | 20 min | 40 min |
| Group I | 8.40 ± 0.13 | 4.40 ± 0.24* | 5.32 ± 0.05* | 4.98 ± 0.18* | 4.16 ± 0.42* |
| Group II | 10.22 ± 0.30 | 4.36 ± 0.37* | 4.94 ± 0.29* | 4.30 ± 0.50* | 4.92 ± 0.67* |
| Group III | 11.38 ± 1.53 | 7.04 ± 0.72* | 4.92 ± 0.72* | 4.04 ± 0.71* | 3.92 ± 0.73* |
| Group IV | 10.73 ± 0.49 | 5.98 ± 0.49* | 4.82 ± 1.06* | 3.93 ± 1.12* | 3.53 ± 0.20* |
| Group V | 8.06 ± 0.63 | 4.78 ± 0.79* | 3.98 ± 0.75* | 3.70 ± 0.70* | 2.58 ± 0.65* |
| Group VI | 9.66 ± 0.96 | 6.86 ± 1.19* | 6.46 ± 1.06* | 6.00 ± 0.71* | 5.20 ± 1.10* |
| Group VII | 10.03 ± 0.59 | 5.79 ± 0.62* | 5.96 ± 0.41* | 5.06 ± 1.25* | 4.17 ± 0.83* |
| Group VIII | 9.51 ± 0.35 | 5.29 ± 0.45* | 4.02 ± 0.37* | 3.95 ± 0.48* | 2.79 ± 0.63* |
| Group IX | 9.67 ± 0.28 | 6.19 ± 1.02* | 5.39 ± 1.02* | 5.26 ± 0.63* | 3.82 ± 0.63* |
| Group X | 9.52 ± 0.69 | 7.03 ± 0.54* | 6.08 ± 0.97* | 5.49 ± 0.37* | 4.94 ± 0.47* |
Coronary flow rate was measured after stabilization (basal), 5,10, 20 and 40 min after reperfusion (R). Group I : control group (ischemia-reperfusion); Group II : ischeamic preconditioning group; Group III: garlic extract treatment group; Group IV : garlic + ischeamic preconditioning group; Group V: ischeamic preconditioning + theophylline treatment group; Group VI: ischeamic preconditioning + 8-SPT treatment group; Group VII: garlic + theophylline treatment group; Group VIII : garlic + 8-SPT treatment group; Group IX : garlic + ischeamic preconditioning + theophylline treatment group; Group X : garlic + ischemic preconditioning + 8-SPT treatment group; n = 6 for each group, *P < 0.05 vs control.
(mL/min, ±s)
Heart rate in isolated rat heart subjected to global ischaemia (20 min) and reperfusion (40 min).
| Groups | Basal | 5 min | 10 min | 20 min | 40 min |
| Group I | 215 ± 30 | 224 ± 20* | 194 ± 20* | 186 ± 15* | 192 ± 10* |
| Group II | 228 ± 35 | 240 ± 30* | 210 ± 30* | 204 ± 30* | 196 ± 30* |
| Group III | 246 ± 18 | 256 ± 31* | 234 ± 08* | 222 ± 13* | 213 ± 22* |
| Group IV | 267 ± 22 | 302 ± 13* | 278 ± 26* | 243 ± 28* | 240 ± 07* |
| Group V | 212 ± 12 | 224 ± 23* | 212 ± 15* | 196 ± 15* | 208 ± 20* |
| Group VI | 216 ± 26 | 220 ± 19* | 194 ± 17* | 192 ± 08* | 184 ± 10* |
| Group VII | 228 ± 23 | 236 ± 22* | 229 ± 18* | 216 ± 26* | 224 ± 06* |
| Group VIII | 217 ± 24 | 222 ± 24* | 216 ± 25* | 212 ± 14* | 201 ± 16* |
| Group IX | 232 ± 19 | 247 ± 26* | 227 ± 28* | 221 ± 28* | 219 ± 24* |
| Group X | 221 ± 33 | 249 ± 31* | 218 ± 32* | 218 ± 21* | 202 ± 27* |
Heart rate was measured after stabilization (basal), 5, 10, 20 and 40 min after reperfucion (R). Group I : control group (ischemia-reperfusion); Group II : ischeamic preconditioning group; Group III : garlic extract treatment group; Group IV: garlic + ischemic preconditioning group; Group V: ischeamic preconditioning + theophylline treatment group; Group VI : ischeamic preconditioning + 8-SPT treatment group; Group VII: garlic + theophylline treatment group; Group VIII : garlic + 8-SPT treatment group; Group IX : garlic + ischeamic preconditioning + theophylline treatment group; Group X : garlic + ischemic preconditioning + 8-SPT treatment group; n = 6 for each group, *P < 0.05 vs control.
(beats/min, mean±SEM)
Myocardial infarct size by volume method in isolated rat heart after subjected to global ischamia (20 min) followed by reperfusion (40 min).
| Groups | Percentage infarct |
| Group I | 50.167 ± 0.832 |
| Group II | 30.010 ± 0.787* |
| Group III | 25.197 ± 1.061* |
| Group IV | 16.480 ± 0.612* |
| Group V | 34.687 ± 0.505* |
| Group VI | 49.437 ± 1.061 |
| Group VII | 28.415 ± 0.373* |
| Group VIII | 41.922 ± 1.020* |
| Group IX | 23.597 ± 0.573* |
| Group X | 37.845 ± 1.044 |
Group I : control group (ischemia-reperfusion); Group II : ischeamic preconditioning group; Group III: garlic extract treatment group; Group
IV: garlic + ischeamic preconditioning group; Group V : ischeamic preconditioning + theophylline treatment group; Group VI: ischeamic preconditioning + 8-SPT treatment group; Group VII: garlic + theophylline treatment group; Group VIII : garlic + 8-SPT treatment group; Group IX : garlic + ischeamic preconditioning + theophylline treatment group; Group X : garlic + ischeamic preconditioning + 8-SPT treatment group. n = 6 for each group,*P < 0.05 vs control.
(%,mean±SEM)
Lactate dehydrogenase (LDH) release in coronary effluent of isolated rat heart at 15 min reperfusion, subjected to global ischemia (20 min) followed by reperfusion (40 min).
| Groups | LDH(U/L) |
| Group I | 838.000 ± 1.897 |
| Group II | 495.333 ± 6.146* |
| Group III | 413.000 ± 4.333* |
| Group IV | 276.167 ± 4.556* |
| Group V | 627.667 ± 4.080* |
| Group VI | 823.667 ± 4.469 |
| Group VII | 493.000 ± 5.404* |
| Group VIII | 790.000 ± 7.233* |
| Group IX | 700.167 ± 5.782* |
| Group X | 769.723 ± 3.483 |
Group I: control group (ischemia-reperfusion); Group II : ischeamic preconditioning group; Group III: garlic extract treatment group; Group IV: garlic + ischeamic preconditioning group; Group V: ischeamic preconditioning + theophylline treatment group; Group VI : ischeamic preconditioning + 8-SPT treatment group; Group VII: garlic + theophylline treatment group; Group VIII: garlic + 8-SPT treatment group; Group IX : garlic + ischeamic preconditioning + theophylline treatment group; Group X: garlic + ischeamic preconditioning + 8-SPT treatment group. n = 6 for each group,*P < 0.05 vs control.
(IU/L, ±s)
Nitrite release at basal, immediate (5 min reperfusion) and 40 min reperfusion in coronary effluent of isolated rat heart subjected to global ischemia (20 min) followed by reperfusion (40 min)
| Groups | Time point | Nitrite release (µg/mL) |
| Group I | Basal | 521.000 ± 1.238 |
| Immediate reperfusion | 530.667 ±1.054 | |
| 40 min reperfusion | 510.000 ± 1.317 | |
| Group II | Basal | 669.167 ±1.046* |
| Immediate reperfusion | 701.000 ± 1.390* | |
| 40 min reperfusion | 650.500 ± 0.992* | |
| Group III | Basal | 860.333 ± 13.288* |
| Immediate reperfusion | 866.833 ± 13.833* | |
| 40 min reperfusion | 838.167 ± 12.081* | |
| Group IV | Basal | 956.333 ± 6.393* |
| Immediate reperfusion | 972.167 ± 2.931* | |
| 40 min reperfusion | 963.573 ± 4.321* | |
| Group V | Basal | 480.000 ± 1.033* |
| Immediate reperfusion | 490.000 ± 1.033* | |
| 40 min reperfusion | 480.833 ± 0.703* | |
| Group VI | Basal | 420.333 ± 5.649* |
| Immediate reperfusion | 448.667 ± 5.283* | |
| 40 min reperfusion | 446.167 ± 17.895* | |
| Group VII | Basal | 439.500 ± 1.232* |
| Immediate reperfusion | 489.833 ± 0.910* | |
| 40 min reperfusion | 471.000 ± 1.390* | |
| Group VIII | Basal | 547.333 ± 17.795* |
| Immediate reperfusion | 564.000 ± 14.656* | |
| 40 min reperfusion | 541.167 ± 13.152* | |
| Group IX | Basal | 421.667 ± 1.810* |
| Immediate reperfusion | 469.667 ± 0.989* | |
| 40 min reperfusion | 441.000 ± 1.713* | |
| Group X | Basal | 614.000 ± 5.944* |
| Immediate reperfusion | 671.667 ± 5.277* | |
| 40 min reperfusion | 635.833 ± 5.588* |
Group I : control group (ischemia-reperfusion); Group II : ischeamic preconditioning group; Group III : Garlic extract treatment group; Group IV: garlic + ischeamic preconditioning group; Group V: ischeamic preconditioning + theophylline treatment group; Group VI: ischeamic preconditioning + 8-SPT treatment group; Group VII : garlic + theophylline treatment group; Group VIII : garlic + 8-SPT treatment group; Group IX : garlic + ischeamic preconditioning + theophylline treatment group; Group X: garlic + ischeamic preconditioning + 8-SPT treatment group, n = 6 for each group,*P < 0.05 vs control.
(µg/mL, ±s)
Adenosine release at basal, immediate (5 min reperfusion) and 40 min reperfusion in coronary effluent of isolated rat heart subjected to global ischemia (20 min) followed by reperfusion (40 min).
| Groups | Time point | Nitrite release (µg/ml) |
| Group I | Basal | 630.333 ± 7.219 |
| Immediate reperfusion | 662.000 ± 4.829 | |
| 30 min reperfusion | 647.000 ± 1.483 | |
| Group II | Basal | 757.000 ± 1.461* |
| Immediate reperfusion | 769.500 ± 7.575* | |
| 30 min reperfusion | 745.167 ± 2.833* | |
| Group III | Basal | 1005.333 ± 13.032* |
| Immediate reperfusion | 1035.333 ± 3.422* | |
| 30 min reperfusion | 1022.667 ± 3.870* | |
| Group IV | Basal | 1231.749 ± 5.832* |
| Immediate reperfusion | 1247.034 ± 4.824* | |
| 30 min reperfusion | 1243.082 ± 6.829* | |
| Group V | Basal | 584.833 ± 4.542 |
| Immediate reperfusion | 628.500 ± 2.643 | |
| 30 min reperfusion | 615.333 ± 3.393 | |
| Group VI | Basal | 517.667 ± 4.631 |
| Immediate reperfusion | 530.833 ± 3.341 | |
| 30 min reperfusion | 521.333 ± 4.958 | |
| Group VII | Basal | 557.667 ± 5.011 |
| Immediate reperfusion | 571.000 ± 4.050 | |
| 30 min reperfusion | 566.167 ± 2.386 | |
| Group VIII | Basal | 808.000 ± 4.203 |
| Immediate reperfusion | 829.500 ± 2.592 | |
| 30 min reperfusion | 820.333 ± 3.313 | |
| Group IX | Basal | 534.667 ± 3.095 |
| Immediate reperfusion | 565.333 ± 5.004 | |
| 30 min reperfusion | 551.000 ± 4.531 | |
| Group X | Basal | 844.833 ± 3.637 |
| Immediate reperfusion | 862.000 ± 4.865 | |
| 30 min reperfusion | 857.333 ± 2.871 |
Group I : control group (ischemia-reperfusion); Group II : ischeamic preconditioning group; Group III: Garlic extract treatment group; Group IV : garlic + ischeamic preconditioning group; Group V : ischeamic preconditioning + theophylline treatment group; Group VI: ischeamic preconditioning + 8-SPT treatment group; Group VII: garlic + theophylline treatment group; Group VIII: garlic + 8-SPT treatment group; Group IX : garlic + ischeamic preconditioning + theophylline treatment group; Group X: garlic + ischeamic preconditioning + 8-SPT treatment group. n = 6 for each group,*P < 0.05 vs control.
(µmol/mL, ±s)
Fig. 3Electrocardiogram of rats treated with higher doses of aqueous extract of garlic (0.5%, 0.4%, 0.3%, 0.2%, 0.1% and 0.07%) showed arrhythmic, depressed heart rate (cardiodepressant) and mortality at last on 40 min reperfusion.
ECG taken in limb lead-II, on isolated heart, mounted on a Langendorff's appratus. A: Group I , control group. B: Group II , dose 0.1% of garlic aqueous extract (at 5 min reperfusion) found arrhythmic. C: Groups III, dose 0.1% of garlic aqueous extract (at 15 min reperfusion) found arrhythmic and cardio-depressant. D: Groups IV, dose 0.1% of garlic aqueous extract (at 20 min reperfusion) found arrhythmic and cardio-depressant. E: Groups V, dose 0.1% of garlic aqueous extract (at 30 min reperfusion) found complete cardio-depressant. F: Groups VI, dose 0.1% of garlic aqueous extract (at 40 min reperfusion) found complete cardio-depressant and mortality.